NASDAQ:WGS GeneDx Q3 2026 Earnings Report $72.85 +1.89 (+2.66%) As of 03:01 PM Eastern This is a fair market value price provided by Massive. Learn more. ProfileEarnings HistoryForecast GeneDx EPS ResultsActual EPSN/AConsensus EPS $0.07Beat/MissN/AOne Year Ago EPSN/AGeneDx Revenue ResultsActual RevenueN/AExpected Revenue$122.93 millionBeat/MissN/AYoY Revenue GrowthN/AGeneDx Announcement DetailsQuarterQ3 2026Date10/27/2026TimeBefore Market OpensConference Call DateTuesday, October 27, 2026Conference Call Time8:30AM ETConference Call ResourcesEarnings HistoryCompany Profile GeneDx Earnings HeadlinesGeneDx Introduces Easy Order at AAP 2026 to Simplify Genomic Testing in Everyday Pediatric CareOctober 2 at 8:30 AM | businesswire.comGeneDx Stock Is Down 30% In Last 1 Year, Can It Climb Again in 2027?September 24, 2026 | finance.yahoo.comHow options let you do more with less capitalWould you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fraction of the cost? That's the core advantage options offer traders at every level. The Beginner's Guide to Options breaks down leverage, income strategies, and real trade examples in plain English — including a little-known approach many traders use to reduce costs and improve profit potential. Download your free copy before this offer expires.October 2 at 1:00 AM | Base Camp Trading (Ad)GeneDx (NASDAQ:WGS) Trading Down 6.5% - Time to Sell?September 24, 2026 | americanbankingnews.comGeneDx Holdings Corp (WGS) Shares Surge 3.3% -- What GF Score of 65 Tells InvestorsAugust 26, 2026 | gurufocus.comGeneDx Announces Transformative Study Supporting Hospital-Wide Adoption of Rapid Genomic Sequencing at Seattle Children’sAugust 24, 2026 | uk.finance.yahoo.comSee More GeneDx Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like GeneDx? Sign up for Earnings360's daily newsletter to receive timely earnings updates on GeneDx and other key companies, straight to your email. Email Address About GeneDxGeneDx (NASDAQ:WGS) (NASDAQ: WGS) is a precision health company that provides genetic testing and related data services. The company focuses on helping healthcare professionals identify genetic conditions, support diagnosis and treatment decisions, and better understand inherited disease. Its offerings include exome and genome sequencing, testing for rare and undiagnosed disorders, hereditary cancer testing, and other genetic analyses. GeneDx also provides clinical interpretation and reporting intended to help physicians evaluate genetic results in the context of a patient’s symptoms and family history. Founded in 2000, GeneDx has built a business around genomic testing for patients with rare diseases and other inherited conditions. The company serves healthcare providers and patients through its laboratory and digital platforms, with testing availability extending beyond the United States in certain areas. GeneDx became part of the publicly traded organization formerly known as Sema4, which adopted the GeneDx name in 2023.View GeneDx ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles McCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal UpsideMicron’s Earnings Reveal Why the AI Memory Boom May Last LongerAnthropic's IPO Could Put Amazon's and Alphabet's Paper Profits to the TestBoeing’s Fighter Victory Opens the Door to Decades of Defense RevenueCorning and AT&T's $3 Billion Fiber Deal Reveals Where AI Spending Goes NextTarget's Holiday Blitz: Slashing Prices to Capture Market ShareCleared for Takeoff: AAR Corp. Expands Its Aerospace Aftermarket Reach Upcoming Earnings PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
